A global study found that death rates for people with type 2 diabetes are declining in high-income countries, including Asia. The study showed a narrowing life expectancy gap between those with and without diabetes in many jurisdictions.
A study has identified genetic variants that may contribute to the development of chronic immune and inflammatory diseases, such as type 1 diabetes and rheumatoid arthritis, in early childhood. The research found thousands of genetic variants driving gene expression across different conditions.
A genetic risk score can identify individuals at a 3-fold increased risk of developing ischaemic stroke, a devastating condition. This scoring system may require more intensive preventive measures than current guidelines recommend.
A pre-clinical study published in Redox Biology reveals that vitamin E may help preserve heart function after a heart attack by reducing inflammation and oxidative stress. The findings suggest that vitamin E could be an effective and inexpensive therapy for patients with heart attacks, providing new hope for cardiovascular health.
A single viral factor released from HIV-infected cells impairs cholesterol metabolism in uninfected cells, triggering inflammation and contributing to the development of diseases such as dementia, heart disease, and diabetes. Targeted treatment may provide a longer and healthier life for people living with HIV/AIDS.
A morning bout of moderate-intensity exercise improves cognitive performance like decision-making across the day compared to prolonged sitting without exercise. Brief light-intensity walking breaks can also boost short-term memory by disrupting uninterrupted sitting.
A team of researchers has identified biomarkers in the blood that can predict the accumulation of toxic fats in the liver, a sign of early fatty liver disease. The discovery has the potential to lead to a blood test to detect those at risk of advanced fatty liver disease and could represent a new approach in precision medicine.
A new report reveals that over 1.2 million Australians with heart disease are at high risk of future events, emphasizing the need for improved secondary prevention strategies. The 'No Second Chances' report proposes pathways to enhance patient care, including a secondary prevention campaign and increased focus on cardiac rehabilitation.
Researchers have developed a new imaging and platelet targeting chemotherapy agent for early detection and treatment of cancers. The approach holds promise for diagnosing and treating tumors without major side effects.
A recent study on Australian diabetics aged under 50 reveals an alarming rise in end-stage kidney disease, underscoring the need for aggressive risk factor treatment. The research highlights the importance of early intervention to mitigate this trend and alleviate pressure on Australia's kidney dialysis services.
Researchers at Baker Heart and Diabetes Institute found that specific brain signaling promotes heart disease by altering bone marrow stem cells, leading to atherosclerosis. The study highlights the importance of managing stress, anxiety, and pain in controlling this form of hypertension.
Scientists at Baker Heart and Diabetes Institute have identified plasma lipid biomarkers that improve upon traditional risk factors in predicting heart disease and stroke. The new blood test will use up to ten lipid markers to better diagnose heart disease, reclassifying patient risk and guiding treatment.
A study by researchers at the Baker Heart and Diabetes Institute has identified novel lipids in the heart and plasma of exercise-trained mice compared to those with a failing heart. These findings may represent new biomarkers and/or drug targets for Atrial Fibrillation and heart failure.